1,2,3,4,4a,5,6,7-Octahydro-2,5,5-trimethyl-2-naphthol
Common Name: |
1,2,3,4,4a,5,6,7-Octahydro-2,5,5-trimethyl-2-naphthol |
IUPAC Name: |
2,5,5-trimethyl-1,3,4,4a,6,7-hexahydronaphthalen-2-ol |
Molecular Formula: |
C13H22O |
SMILES: |
CC1(CCC=C2C1CCC(C2)(C)O)C |
Inchi: |
1S/C13H22O/c1-12(2)7-4-5-10-9-13(3,14)8-6-11(10)12/h5,11,14H,4,6-9H2,1-3H3 |
Inchi Key: |
GPVOTKFXWGURGP-UHFFFAOYSA-N |
Cas No: |
41199-19-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
194.31 |
Mass (g/mol) |
194.167 |
Molar Refractivity |
60.84 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
0 |
Rings |
2 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
280.00 to 281.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.0005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.85 |
LogP |
3.284 |
iLOGP |
2.70 |
XLOGP3 |
2.77 |
WLOGP |
3.28 |
MLOGP |
3.15 |
ESOL Log S |
-2.79 |
ESOL Solubility (mg/ml) |
0.315 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.85 |
Ali Solubility (mg/ml) |
0.27 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.74 |
Silicos-IT Solubility (mg/ml) |
0.35 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.52 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.954 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.09 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
1 |
OCT2 inhibitor |
0 |